Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2014Alimentary Pharmacology & TherapeuticsOpen Access

A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease

View Full Paper
Ask AI
Bookmark
Share

Authors

BLBarrett G. LevesqueGGGordon R. GreenbergGZGuangyong Zou

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Levesque et al. (2014) studied this question.

synapsesocial.com/papers/6a87ef3f70098fa105bb607chttps://doi.org/10.1111/apt.12733
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient2013 · 348 citations
  2. 2Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease2010 · 175 citations
  3. 3Correlation of C-Reactive Protein With Clinical, Endoscopic, Histologic, and Radiographic Activity in Inflammatory Bowel Disease2005 · 588 citations
  4. 4Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis2009 · 538 citations
  5. 5Development and validation of a homogeneous mobility shift assay for the measurement of infliximab and antibodies-to-infliximab levels in patient serum2012 · 206 citations